MAPT and Alzheimer disease: Notably, recent clinical evidence has demonstrated the presence of Aβ and tau in perilymph of aged cochlear implanting patients, with levels correlating with cognitive decline and age, supporting the relevance of using this model to explore auditory biomarkers of AD(17).